Mechanostimulatory Platform for Improved CAR T Cell Immunotherapy
Advanced Materials · 2025-07 · 37 (29)
DOI: 10.1002/adma.202412482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 09.05.2025. Verfasst von Abed Al-Kader Yassin und 20 weiteren Autor:innen. Beteiligte Einrichtung: The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 84…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, T-Lymphocytes, Immunotherapy, Adoptive. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Israel Innovation Authority, United States-Israel Binational Science Foundation, Cooperation Program in Cancer Research of the Deutsche Krebsforschungszentrum.
Abstract (Originalsprache)
Chimeric Antigen Receptor T (CAR T) cell immunotherapy has revolutionized cancer treatment, yet it is hindered by rapid T‐cell exhaustion caused by uncontrolled activation during CAR generation. Leveraging insights into T‐cell mechanosensing, a novel mechanostimulatory platform is engineered for T‐cell activation based on an antigen‐carrying surface with controlled elasticity and nanotopography. The platform is designed to optimize and balance T‐cell exhaustion, proliferation, and CAR expression. It enhances the differentiation of T cells into the central memory subset, which is crucial for the persistence of CAR T cell therapy's anticancer effects. The platform produces CAR T cells with higher antitumor efficacy, as validated through ex vivo experiments, and with higher in vivo persistence and ability to suppress tumor proliferation, as compared to CAR T cells generated by standard protocols. RNA‐seq analysis confirmed an increased transcriptional signature of central memory T cells. Furthermore, this platform completely eliminates T‐cell toxicity associated with the non‐viral transfection process typically observed with standard activation methods. This platform presents a promising pathway for improving the efficiency and safety of CAR T cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 8410501, Israel.
- Department of Materials Engineering, Faculty of Engineering, Ben-Gurion University of the Negev, Beer-Sheva, 8410501, Israel.
- Ilse Katz Institute for the Nanoscale Science and Technology, Beer-Sheva, Israel.
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Software and Information System Engineering, Ben-Gurion University of the Negev, Beer-Sheva, 8410501, Israel.
ORCID-Profile: Mark Schvartzman
Förderung
- Israel Innovation Authority
- United States-Israel Binational Science Foundation
- Cooperation Program in Cancer Research of the Deutsche Krebsforschungszentrum
- Ministry of Science, Technology and Space
- Deutsche Forschungsgemeinschaft
- Israel Science Foundation
- Israeli Ministry of Science Technology and Space
- Ofiice of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Cancer Research Program
Zitieren
APA
Yassin, A. A., Ureña Martin, C., Le Saux, G., Pandey, A., Tzadka, S., Toledo, E., Pandit, J. J., Sherf, T., Nusbaum, I., Bhattachrya, B., Banerji, R., Greenshpan, Y., Abu Ahmad, M. A., Radinsky, O., Sklartz, M., Gazit, R., Elkabets, M., Ghassemi, S., Cohen, O., …, & Porgador, A. (2025). Mechanostimulatory Platform for Improved CAR T Cell Immunotherapy. Advanced Materials, 37(29). https://doi.org/10.1002/adma.202412482
Vancouver
Yassin AA, Ureña Martin C, Le Saux G, Pandey A, Tzadka S, Toledo E, et al. Mechanostimulatory Platform for Improved CAR T Cell Immunotherapy. Advanced Materials. 2025;37(29). doi:10.1002/adma.202412482
BibTeX
@article{Yassin2025,
author = {Yassin, Abed Al-Kader and Ureña Martin, Carlos and Le Saux, Guillaume and Pandey, Ashish and Tzadka, Sivan and Toledo, Esti and Pandit, Jatin Jawhir and Sherf, Tomer and Nusbaum, Idan and Bhattachrya, Baisali and Banerji, Rajashri and Greenshpan, Yariv and Abu Ahmad, Muhammad Abu and Radinsky, Olga and Sklartz, Menachem and Gazit, Roi and Elkabets, Moshe and Ghassemi, Saba and Cohen, Ofir and Schvartzman, Mark and Porgador, Angel},
title = {Mechanostimulatory Platform for Improved CAR T Cell Immunotherapy},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {29},
doi = {10.1002/adma.202412482}
}
EUVIMED